Open AccessRivaroxaban Causing Thrombocytopenia in a Case of Deep Vein Thrombosis (DVT)
Author(s) -
Twinkle Pawar,
Yash Gupte,
Sourav Chaturvedi,
Abhishek Gupta,
Sourya Acharya
Publication year - 2021
Publication title -
journal of evolution of medical and dental sciences
Language(s) - English
Resource type - Journals
eISSN - 2278-4802
pISSN - 2278-4748
DOI - 10.14260/jemds/2021/548
Subject(s) - rivaroxaban , medicine , dabigatran , edoxaban , apixaban , warfarin , deep vein , thrombosis , anesthesia , surgery , atrial fibrillation
Novel oral anticoagulants (NOACs) are used as alternative to intravenous anticoagulants. It includes apixaban, dabigatran, rivaroxaban and edoxaban.1 Some of the complications induced by these drugs are gastrointestinal haemorrhage, cerebral haemorrhage and rarely thrombocytopenia. We present a rare case report of a selective factor Xa inhibitor rivaroxaban, which induced thrombocytopenia in a case of deep vein thrombosis (DVT) of right lower limb. Drugs commonly used to prevent embolization of systemic circulation are warfarin and novel oral anticoagulants, such as rivaroxaban and dabigatran.